Sorry, this page does not exist (404)
Please use the search box above, or perhaps one of the following pages could be of interest?
-
COX-2 Inhibitors
Since this report was published Merck Sharp & Dohme has decided to withdraw Vioxx (rofecoxib) from the world market. Findings by SBU Alert Version: 1 Technology and target group NSAIDs (non-steroidal
-
Aromatase Inhibitors in Breast Cancer
1SBU Alert is a service provided by SBU in collaboration with the Medical Products Agency, the National Board of Health and Welfare, and the Swedish Association of Local Authorities and Regions.
-
Aromatase Inhibitors in Breast Cancer
Summary and Conclusions Technology and target group Approximately 6 500 new cases of breast cancer are detected annually in Sweden. Early stages of the disease are treated surgically. Various types